icone plus
Contact Abonnez-vous aux actualités
Reason for request
- Re-assessment of Actual Benefit on the transparency Committee’s own initiative in accordance with article R 163-21 of the Social Security Code and changes to Summary of Product Characteristics.
Clinical Benefit
Moderate
The actual benefit of AETOXISCLEROL is moderate.
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
E21YsysJ5JumDEh6
Listen
